SZSE Ticker: 002437

Harbin Gloria Pharmaceuticals Co., Ltd

哈尔滨誉衡药业股份有限公司

誉衡药业

GLORIA PHARM

Listing Date: 2010-06-23

Board: SME

Industry Classification: Manufacturing

Jufeng Early Participation: Shanghai resumption of business and market + lower mortgage interest rate lower limit, A shares will fluctuate upward

Post date May 16, 2022 — 03:29 Post Lock

Yuheng Pharmaceutical: A fire accident occurred in a three-dimensional warehouse of a subsidiary – yqqlm

Post date May 13, 2022 — 18:39 Post Lock

A fire accident occurred in a three-dimensional warehouse of a subsidiary of Yuheng Pharmaceutical Co., Ltd.

Post date May 13, 2022 — 18:38 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 10:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 10:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: New Progress Steps Higher

Post date May 3, 2022 — 08:46 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top Ten Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 08:01 Post Lock

Securities Finance and Asset Management’s Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 3, 2022 — 04:10 Post Lock

Securities Finance and Asset Management’s Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 2, 2022 — 23:10 Post Lock

Securities Finance and Asset Management's Investment Roadmap for the First Quarter Announced: Top 10 Shareholders of New Progressive High Stocks

Post date May 2, 2022 — 22:55 Post Lock

Securities Finance and Asset Management’s investment roadmap for the first quarter announced: the top ten shareholders of new progressive stocks

Post date May 2, 2022 — 20:04 Post Lock

Securities Finance and Asset Management’s investment roadmap for the first quarter announced: the top ten shareholders of high-end stocks before the new increase, the guitar score in an instant, the water to protect the field will be green, the border is blocked, the baby is crying, the second is learning games

Post date May 2, 2022 — 20:01 Post Lock

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks’ revenue and net profit will double, and BeiGene will become the “loss king” – yqqlm

Post date May 1, 2022 — 04:00 Post Lock

[V View 2021 Annual Report] In 2021, 60% of pharmaceutical stocks will increase in revenue and net profit, and BeiGene will become the "loss king"-Stock Channel-Hexun.com

Post date May 1, 2022 — 04:00 Post Lock

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG

Post date April 19, 2022 — 09:35 Post Lock

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG Xinhua

Post date April 19, 2022 — 09:30 Post Lock

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG PD-1 Junshi Biotechnology Listed Company_Sina Technology_Sina

Post date April 19, 2022 — 07:36 Post Lock

The competition of innovation and R&D strength of listed pharmaceutical companies shows the dual benefits of business and ESG_Individual Stock Information_Market Gold Online

Post date April 19, 2022 — 07:31 Post Lock

SINBON PHARMACEUTICAL (002390): Announcement on Expected Daily Connected Transactions in 2022- CFi.CN Zhongcai Network

Post date April 15, 2022 — 04:20 Post Lock

Yuheng Pharmaceutical: The bankruptcy and reorganization of the company's controlling shareholder is still in the process of progress, and there is no substantial progress yet.

Post date April 12, 2022 — 10:57 Post Lock

Want to see more data? Registered subscribers can see all the data.